N-(4-{4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}phenyl)-3-methoxybenzamide

Catalog No. :
ACHOJA985
CAS No. :
478262-22-5
Molecular Formula :
C24H22ClF3N4O2
Molecular Weight :
490.91

IUPAC Name:N-(4-(4-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)phenyl)-3-methoxybenzamide

N-(4-{4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}phenyl)-3-methoxybenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-{4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}phenyl)-3-methoxybenzamide
IUPAC NameN-(4-(4-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)phenyl)-3-methoxybenzamide
Molecular FormulaC24H22ClF3N4O2
Molecular Weight490.91
SMILESO=C(NC1=CC=C(N2CCN(C3=NC=C(C(F)(F)F)C=C3Cl)CC2)C=C1)C4=CC=CC(OC)=C4
InChI KeySRCCPXGWDLDPSG-UHFFFAOYSA-N
SynonymN-(4-(4-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]PIPERAZINO)PHENYL)-3-METHOXYBENZENECARBOXAMIDE;N-(4-{4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}phenyl)-3-methoxybenzamide;Benzamide, N-[4-[4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-1-piperazinyl]phenyl]-3-methoxy-
CAS No.478262-22-5

Synthetic Route by SureRoute

1. ACHOJA985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHOJA985 route product structure diagram
    ACHOJA985478262-22-5
Inquiry

2. ACHOJA985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGKIH458 route compound structure diagram
    ACGKIH458586-38-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHOJA985 route product structure diagram
    ACHOJA985478262-22-5
Inquiry

Comments (0)